SHARE

Sanofi invests $625m to boost venture capital arm

Sanofi is injecting $625m into Sanofi Ventures to expand investments in biotechnology and digital health. The fund, now managing over $1.4bn, will continue to focus on immunology, rare diseases, neurology and vaccines to support innovation.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.